[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355359-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355359-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","advances-in-spatial-multi-omics-in-gastric-cancer","Advances in Spatial Multi-Omics in Gastric Cancer","","Gastric cancer (GC) remains a major global health burden, with unfavorable outcomes driven largely by extensive tumor heterogeneity. Conventional bulk omics average signals across diverse cell populations and cannot resolve spatial molecular differences within the tumor and its tumor microenvironment (TME). Single-cell omics adds cellular heterogeneity but lacks spatial context. Spatial multi-omics is therefore urgently needed to deliver high-definition dissection of GC heterogeneity and to improve therapeutic efficacy. This review summarizes spatial technologies, their impact on molecular classification, biomarker discovery, and the cellular interactions underlying immune evasion and metastasis, while outlining mechanisms of resistance and current translational bottlenecks.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/advances-in-spatial-multi-omics-in-gastric-cancer/355359/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/advances-in-spatial-multi-omics-in-gastric-cancer/355359.png","ImageObject",300,407,{"name":42,"@type":43},"Jake","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is spatial multi-omics needed for gastric cancer research?","Question",{"text":63,"@type":64},"Because bulk omics averages signals across heterogeneous cell populations and single-cell omics lacks spatial context. Spatial multi-omics preserves spatial coordinates while enabling deep molecular characterization, helping resolve GC heterogeneity and guide therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does spatial omics improve understanding of tumor heterogeneity in GC?",{"text":68,"@type":64},"It distinguishes molecular differences across regions of the same tumor and within the tumor microenvironment, supporting more refined molecular classification beyond traditional models.",{"name":70,"@type":61,"acceptedAnswer":71},"What roles does spatial profiling play in therapeutic resistance?",{"text":72,"@type":64},"Spatial profiling helps unravel multidimensional mechanisms of resistance to chemotherapy, targeted therapy, and immunotherapy by identifying spatially distinct drug-resistant subpopulations and local resistance interactions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355359,1790243799,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Review  \nAdvances in Spatial Multi-Omics in Gastric Cancer  \nHongfei Yan 1 and Yang Liu 1,2,3, *  \nAcademic Editor: Elizabeth Neumann  \nReceived: 9 February 2026  \nRevised: 6 March 2026  \nAccepted: 9 March 2026  \nPublished: 17 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Pathology, Yale School of Medicine, New Haven, CT 06510, USA  \n2 Department of Neurology, Yale School of Medicine, New Haven, CT 06510, USA  \n3 Yale Cancer Center, Yale School of Medicine, New Haven, CT 06510, USA  \n* [Correspondence: yang.liu.yl2224@yale.edu](Correspondence: yang.liu.yl2224@yale.edu)  \nAbstract  \nGastric cancer (GC) remains a major global health burden, with its unfavorable prognosis primarily driven by extensive tumor heterogeneity. Traditional bulk omics, while informative, are inherently limited by the averaging effect of diverse cell populations and fail to capture the critical spatial molecular disparities within the tumor and its microenvironment (TME) . Single-cell omics can capture cellular heterogeneity but lack spatial context. Therefore, there is an urgent clinical need for spatial multi-omics to provide a high-definition dissection of GC heterogeneity and to optimize therapeutic efficacy. This review first outlines briefly the evolution of spatial technologies, including transcriptomics, proteomics, metabolomics, genomics and epigenomics, and their transformative applications in GC research. We further explore how these platforms refine molecular classification beyond traditional models, identify next-generation biomarkers, and decode the intricate cellular interactions governing immune evasion and metastasis. Next, we highlight the pivotal role of spatial profiling in unravelling the multidimensional mechanisms of resistance to chemotherapy, targeted therapy and immunotherapy. Finally, we address current technical bottlenecks and discuss prospects for clinical translation.  \nKeywords: gastric cancer; spatial multi-omics; tumor microenvironment; therapeutic resistance; precision medicine  \n1. Introduction  \nGastric cancer (GC) is a major global health burden with high morbidity and mortality [1,2] . Despite advances in multimodal treatment strategies, including surgery, chemoradiotherapy and immunotherapy, the 5-year survival rate for GC remains below 40%[3] . Current GC diagnosis relies on imaging studies combined with endoscopic biopsy, which not only enables initial tumor cell characterization but also detects key molecular markers such as HER2, microsatellite stability and Claudin 18.2 [4] . These results support multidisciplinary teams in formulating treatment plans that are more personalized than previous approaches, while surgical specimens further allow pathologists to analyze the tumor’s molecular spectrum to inform subsequent therapy personalization. The poor clinical outcome of GC is largely attributable to the extensive heterogeneity of the tumor. This heterogeneity exists not only between patients (inter-patient heterogeneity) but also within distinct regions of the same tumor (intra-tumoral heterogeneity) and across the tumor microenvironment [5,6] . It serves as a fundamental driver of poor therapeutic response, recurrence, and drug resistance, posing a significant barrier to the development and implementation of precision oncology [7–9] . An in-depth characterization of GC from  \na spatiotemporal perspective, encompassing molecular, cellular and tissue levels, is essential for deciphering tumor heterogeneity, optimizing therapeutic efficacy and ultimately improving patient survival.  \nAlthough traditional bulk omics offer a broad overview of molecular landscapes, they are intrinsically constrained by signal averaging across heterogeneous cell populations, thereby obscuring intra-tumoral heterogeneity. To address this, single-cel","cbCaiuXlnHHJ14VX","https://ap.wps.com/l/cbCaiuXlnHHJ14VX","pdf",2805710,29,"English","# Introduction\n# Spatial Omics Technologies\n## Spatial Transcriptomics","[{\"question\":\"Why is spatial multi-omics needed for gastric cancer research?\",\"answer\":\"Because bulk omics averages signals across heterogeneous cell populations and single-cell omics lacks spatial context. Spatial multi-omics preserves spatial coordinates while enabling deep molecular characterization, helping resolve GC heterogeneity and guide therapy.\"},{\"question\":\"How does spatial omics improve understanding of tumor heterogeneity in GC?\",\"answer\":\"It distinguishes molecular differences across regions of the same tumor and within the tumor microenvironment, supporting more refined molecular classification beyond traditional models.\"},{\"question\":\"What roles does spatial profiling play in therapeutic resistance?\",\"answer\":\"Spatial profiling helps unravel multidimensional mechanisms of resistance to chemotherapy, targeted therapy, and immunotherapy by identifying spatially distinct drug-resistant subpopulations and local resistance interactions.\"}]","Advances in Spatial Multi-Omics in Gastric Cancer | PDF",1790118062,73,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89462f655a2233746bb8172430b8d313.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc1f89f5e54bf685f43561393405864a.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bc678326648557a8086946aa3c458b1.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/008bc0aede0f41aacf31e852b0e69079.webp",980,1385]